acid reducer maximum strength

Generic: famotidine

Labeler: dr.reddys laboratories inc.
NDC Directory HUMAN OTC DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name acid reducer maximum strength
Generic Name famotidine
Labeler dr.reddys laboratories inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

famotidine 20 mg/1

Manufacturer
Dr.Reddys Laboratories Inc.

Identifiers & Regulatory

Product NDC 43598-960
Product ID 43598-960_04bc02ec-359b-bf7a-d622-4c8ee4075397
Product Type HUMAN OTC DRUG
Marketing Category ANDA
Application Number ANDA077367
Listing Expiration 2026-12-31
Marketing Start 2020-09-01

Pharmacologic Class

Established (EPC)
histamine-2 receptor antagonist [epc]
Mechanism of Action
histamine h2 receptor antagonists [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 43598960
Hyphenated Format 43598-960

Supplemental Identifiers

RxCUI
199047 310273
UNII
5QZO15J2Z8
NUI
N0000000151 N0000175784

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name acid reducer maximum strength (source: ndc)
Generic Name famotidine (source: ndc)
Application Number ANDA077367 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 20 mg/1
source: ndc
Packaging
  • 1 BOTTLE in 1 CARTON (43598-960-32) / 170 TABLET in 1 BOTTLE
  • 1 BOTTLE in 1 CARTON (43598-960-65) / 65 TABLET in 1 BOTTLE
  • 1 BOTTLE in 1 CARTON (43598-960-91) / 90 TABLET in 1 BOTTLE
source: ndc

Packages (3)

43598-960-32 1 BOTTLE in 1 CARTON (43598-960-32) / 170 TABLET in 1 BOTTLE 43598-960-65 1 BOTTLE in 1 CARTON (43598-960-65) / 65 TABLET in 1 BOTTLE 43598-960-91 1 BOTTLE in 1 CARTON (43598-960-91) / 90 TABLET in 1 BOTTLE

Ingredients (1)

famotidine (20 mg/1)

Linked Drug Pages (1)

Acid Reducer Original Strength, Acid Reducer Maximum Strength ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "04bc02ec-359b-bf7a-d622-4c8ee4075397", "openfda": {"nui": ["N0000000151", "N0000175784"], "unii": ["5QZO15J2Z8"], "rxcui": ["199047", "310273"], "spl_set_id": ["ca039876-f7e5-3e60-da5a-a1f40637a417"], "pharm_class_epc": ["Histamine-2 Receptor Antagonist [EPC]"], "pharm_class_moa": ["Histamine H2 Receptor Antagonists [MoA]"], "manufacturer_name": ["Dr.Reddys Laboratories Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (43598-960-32)  / 170 TABLET in 1 BOTTLE", "package_ndc": "43598-960-32", "marketing_start_date": "20200901"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (43598-960-65)  / 65 TABLET in 1 BOTTLE", "package_ndc": "43598-960-65", "marketing_start_date": "20200901"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (43598-960-91)  / 90 TABLET in 1 BOTTLE", "package_ndc": "43598-960-91", "marketing_start_date": "20211007"}], "brand_name": "Acid Reducer Maximum Strength", "product_id": "43598-960_04bc02ec-359b-bf7a-d622-4c8ee4075397", "dosage_form": "TABLET", "pharm_class": ["Histamine H2 Receptor Antagonists [MoA]", "Histamine-2 Receptor Antagonist [EPC]"], "product_ndc": "43598-960", "generic_name": "Famotidine", "labeler_name": "Dr.Reddys Laboratories Inc.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Acid Reducer", "brand_name_suffix": "Maximum Strength", "active_ingredients": [{"name": "FAMOTIDINE", "strength": "20 mg/1"}], "application_number": "ANDA077367", "marketing_category": "ANDA", "marketing_start_date": "20200901", "listing_expiration_date": "20261231"}